82% (n=9/11) of patients who received felzaltamab experienced resolution of symptoms. Antibody-mediated rejection The proportion of patients meeting the Banff criteria in the 24-week biopsy was significantly increased compared to …
Tag:
HIBio
-
Kidney Transplantation
-
The study evaluated the safety and tolerability of felzalutamab in adults who experienced late AMR at least six months after kidney transplantation. Credit: mi_viri / Shutterstock.com Human Immunology Biosciences (HI-Bio) …